BioElectronics set to market its Allay product in Chinese market

NewsGuard 100/100 Score

BioElectronics Corporation (PINKSHEETS:BIEL), the maker of inexpensive, disposable, drug-free, anti-inflammatory devices, today announces its entry into one most dynamic and fastest growing economies in the world, the People's Republic of China.

BioElectronics in conjunction with its Chinese partner, Project Asia, plan to begin test marketing a new direct response television campaign for the BioElectronics Allay product during mid-February with full marketing efforts commencing shortly thereafter.

“We look forward to making BioElectronics’s market entry into the Chinese marketplace a significant success.”

“For the past few months we have been working very hard to finalize our relationship with several Chinese partners, in conjunction with Project Asia, all of whom have a high level of interest in marketing the Allay product within the People's Republic of China,” said Andrew Whelan, CEO of BioElectronics Corporation. “Last week, we finished shooting our direct response television campaign spots in Mandarin and we have recently finalized e-commerce web designs and methodologies for fulfillment operations. We will be traveling to China with representatives from Project Asia in mid-January to meet with government representatives and television station executives to finalize details of the marketing campaign. We are looking forward to beginning test marketing in this fast growing market. While we are excited about the Chinese market opportunity, we want to emphasize that China is just one of many opportunities we are currently pursuing. Similar marketing campaigns are in various phases of launch in Canada, Latin America, Western Europe, and Japan.”

“We believe the Allay product is perfect for the Chinese marketplace and a direct response television-oriented marketing campaign. Credit card usage within the People’s Republic of China is growing at a very fast rate, especially within the large urban areas where we will be placing our emphasis,” said Marc Weiss, President of Project Asia. “We look forward to making BioElectronics’s market entry into the Chinese marketplace a significant success.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ketamine's rapid impact on depression linked to immune system pathways